Celecoxib for schizophrenia

Akhondzadeh, Shahin; Modabbernia, Amirhossein; Taslimi, Shervin; Daneshmand, Ali; Ostovaneh, Mohammadreza

doi:10.1002/14651858.cd009205

Cited by 3 publications

(1 citation statement)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A protocol for this Cochrane Review was previously published (Akhondzadeh 2011), and the current team of review authors have taken over the title to complete this research. Elements from the previous author team's protocol have been used as the basis of this protocol and we would like to acknowledge the previous team (Akhondzadeh S, Modabbernia A, Taslimi S, Daneshmand A, Ostovaneh MR) for their contributions.…”

Section: A C K N O W L E D G E M E N T Smentioning

confidence: 99%

Celecoxib plus standard care for people with schizophrenia

Kotecha

Upthegrove

2018

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Where a licence is displayed above, please note the terms and conditions of the licence govern your use of this document.When citing, please reference the published version. Take down policyWhile the University of Birmingham exercises care and attention in making items available there are rare occasions when an item has been uploaded in error or has been deemed to be commercially or otherwise sensitive.

show abstract

Section: A C K N O W L E D G E M E N T Smentioning

confidence: 99%

Celecoxib plus standard care for people with schizophrenia

Kotecha

Upthegrove

2018

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

show abstract

Selective noradrenaline reuptake inhibitors for schizophrenia

Matthews¹,

Horder

Pearce

2018

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Acetylsalicylic acid (aspirin) for schizophrenia

Schmidt

Phelps

Friedel

et al. 2019

Cochrane Database of Systematic Reviews

View full text Add to dashboard Cite

Analysis 1.1. Comparison 1 Aspirin plus antipsychotics versus placebo plus antipsychotics), Outcome 1 Global state: any change-unspecified problem necessitating change in dose or type of antipsychotics-medium term.. .. . Analysis 1.2. Comparison 1 Aspirin plus antipsychotics versus placebo plus antipsychotics), Outcome 2 Mental state: 1. General-mean endpoint score (Positive and Negative Symptom Scale (PANSS) total, high = poor).. .. . Analysis 1.3. Comparison 1 Aspirin plus antipsychotics versus placebo plus antipsychotics), Outcome 3 Mental state: 2. Specific-negative symptoms-mean endpoint score (PANSS negative, high = poor).. .. .. .. .. Analysis 1.4. Comparison 1 Aspirin plus antipsychotics versus placebo plus antipsychotics), Outcome 4 Mental state: 3.

show abstract

Celecoxib for schizophrenia

Cited by 3 publications

References 31 publications

Celecoxib plus standard care for people with schizophrenia

Celecoxib plus standard care for people with schizophrenia

Selective noradrenaline reuptake inhibitors for schizophrenia

Acetylsalicylic acid (aspirin) for schizophrenia

Contact Info

Product

Resources

About